Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 9, 2008 6:58:47 AM CDT



Doctors Paid Millions To Use Anemia Drugs

Posted May 9, 07 8:34 AM CDT in Science & Health    Editor's Choice

(Newser) – Doctors are paid millions of dollars by drug companies to give their patients anemia medicine which regulators now say may be dangerous. Spurred by competiton between several similar drugs, companies reward doctors with rebates, which allow them to make a significant profit, the New York Times reports.

But a new FDA study reveals that the drugs often don't work and may shorten patients' lives in high doses. The drugs—Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson—are given to a milion patients every year to treat anemia caused by kidney disease or chemotherapy, and represent Medicare's single largest drug expense.

Source New York Times

Stethoscope   ((c) ernstl)
prev    next
play

Threads (1 of 3)

Tags

health   medicine   FDA   doctor   safety   pharmaceutical companies   Medicare   drug companies   Johnson and Johnson   Amgen   Anemia



Loading...

Loading...

Today's Most Popular


Other Home Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »